Search Results - Bluemn, Eric G.

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Endovascular-First Treatment of Peripheral Arterial Disease Remains Controversial

    Endovascular-First Treatment of Peripheral Arterial Disease Remains Controversial by Bluemn, Eric G., MD, PhD, Simons, Jessica P., MD, MPH, Messina, Louis M., MD

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling

    Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling by Bluemn, Eric G., Coleman, Ilsa M., Lucas, Jared M., Coleman, Roger T., Hernandez-Lopez, Susana, Tharakan, Robin, Bianchi-Frias, Daniella, Dumpit, Ruth F., Kaipainen, Arja, Corella, Alexandra N., Yang, Yu Chi, Nyquist, Michael D., Mostaghel, Elahe, Hsieh, Andrew C., Zhang, Xiaotun, Corey, Eva, Brown, Lisha G., Nguyen, Holly M., Pienta, Kenneth, Ittmann, Michael, Schweizer, Michael, True, Lawrence D., Wise, David, Rennie, Paul S., Vessella, Robert L., Morrissey, Colm, Nelson, Peter S.

    Published in Cancer cell
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    PPP2R2C loss promotes castration-resistance and is associated with increased prostate cancer-specific mortality

    PPP2R2C loss promotes castration-resistance and is associated with increased prostate cancer-specific mortality by Bluemn, Eric G, Spencer, Elysia Sophie, Mecham, Brigham, Gordon, Ryan R, Coleman, Ilsa, Lewinshtein, Daniel, Mostaghel, Elahe, Zhang, Xiaotun, Annis, James, Grandori, Carla, Porter, Christopher, Nelson, Peter S

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Merkel cell polyomavirus is not detected in prostate cancers, surrounding stroma, or benign prostate controls

    Merkel cell polyomavirus is not detected in prostate cancers, surrounding stroma, or benign prostate controls by Bluemn, Eric G, Paulson, Kelly G, Higgins, Erin E, Sun, Yu, Nghiem, Paul, Nelson, Peter S

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    NESVS12. Analysis of 30-Day Readmission After Infrainguinal Bypass: Lessons Learned from a Trial of 30-Day Data Collection in the Vascular Study Group of New England

    NESVS12. Analysis of 30-Day Readmission After Infrainguinal Bypass: Lessons Learned from a Trial of 30-Day Data Collection in the Vascular Study Group of New England by Bluemn, Eric G., Flahive, Julie M., Aiello, Francesco A., Bertges, Daniel J., Farber, Alik, Goodney, Philip P., Jorgensen, Jens, Schanzer, Andres, Simons, Jessica P.

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Abstract IA21: AR is ablated: Now what? Targeting the double-negative phenotype

    Abstract IA21: AR is ablated: Now what? Targeting the double-negative phenotype by Morrissey, Colm, Bluemn, Eric G., Coleman, Ilsa M., Lucas, Jared M., Coleman, Roger T., Tharakan, Robin, Bianchi-Frias, Daniella, Dumpit, Ruth F., Kaipainen, Arja, Corella, Alexandra N., Yang, Yu Chi, Nyquist, Michael D., Mostaghel, Elahe, Zhang, Xiaotun, Corey, Eva, Brown, Lisha G., Nguyen, Holly M., Schweizer, Michael, True, Lawrence D., Rennie, Paul S., Vessella, Robert L., Nelson, Peter S.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: